Results 291 to 300 of about 65,144 (350)

Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France

Fundamental &Clinical Pharmacology, Volume 39, Issue 4, August 2025.
ABSTRACT Background Seizures after the use of cannabinoids are reported, but no precise descriptions of the characteristics of subjects and factors that may trigger seizures are available. Objectives To study the characteristics and circumstances associated with the occurrence of seizures in individuals using cannabinoids for medical or recreational ...
Marie‐Laure Laroche, Marion Labetoulle, Emilie Jouanjus, Edeltraut Kröger, Arsène Zongo   +4 more
wiley   +1 more source

Adverse Cutaneous Reactions Following COVID-19 Vaccination Among Patients with Pre-Existing Urticaria: A Cross-Sectional Study at a Tertiary Care Center in Saudi Arabia. [PDF]

Int J Gen Med
Asiri A, Alotaibi HM, Alotaibi NA, Alsaleem AA.   +3 more
europepmc   +1 more source

Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study. [PDF]

Transl Lung Cancer Res
Zhang WH, Li BX, Ma CX, Wang J, Yang F, Xiong YJ, Li SZ, Zhang JL, Du WJ, Hui ZZ, Shen M, Zhou L, Li RM, Tian X, Han Y, Ren BZ, Ichiki Y, Lee SC, Zhang XW, Cao S, Ren XB, Liu L.   +21 more
europepmc   +1 more source

Chronic urticaria treatment challenges in children. [PDF]

Rev Paul Pediatr
Ensina LF, Brandão LS, Melo ACDB, Antila M, Ben-Shoshan M, Solé D.   +5 more
europepmc   +1 more source

Successful coil embolization of 3 pulmonary arteriovenous malformations using a gadolinium contrast agent in a patient with severe iodine allergy: A case report. [PDF]

Radiol Case Rep
Kamisako A, Ikoma A, Sonomura T, Naka T, Miyake Y, Mimura R, Tamai K, Murotani K, Minamiguchi H.   +8 more
europepmc   +1 more source